Skip to main content
Back to General Catalyst

General Catalyst's Therapeutics Portfolio

Browse 7 Therapeutics companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
7
Total Funding in Therapeutics
$450.5M

Therapeutics Portfolio Companies (7)

Export
BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$213.0M
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalService IndustryTherapeutics

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.

San Diego, United States
April 2026
$100.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

South San Francisco, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

19,000+ verified contacts

Health CareMental HealthmHealthTherapeuticsWellness

Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.

Cambridge, United States
August 2025
$35.2M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

South San Francisco, United States
August 2025
$30.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio